NCT00433667View on ClinicalTrials.gov

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

PHASE3CompletedINTERVENTIONAL

Enrollment

563

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

EpilepsyEpilepsy, FocalSeizure DisorderComplex Partial SeizuresEpilepsy, Complex Partial

Interventions

DRUG

RWJ-333369

All Listed Sponsors

lead

SK Life Science, Inc.

INDUSTRY

NCT00433667 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. | Biotech Hunter | Biotech Hunter